Biological Trace Element Research

, Volume 133, Issue 3, pp 284–290 | Cite as

Comparative Analysis of Serum Manganese, Zinc, Calcium, Copper and Magnesium Level in Panic Disorder Patients

  • Zabun Nahar
  • Mohammad Abul Kalam Azad
  • Md Ashrafur Rahman
  • Mohammad Arifur Rahman
  • Wasimul Bari
  • Sheikh Nazrul Islam
  • Md Saiful Islam
  • Abul HasnatEmail author


The purpose of the study was to determine the serum concentration of trace elements of panic disorder patients and to find out the relationship between trace element levels and nutritional status or socio-economic factors. The study was conducted among 54 panic disorder patients and 52 healthy volunteers. Patients were recruited from Bangabandhu Sheikh Mujib Medical University by random sampling. Serum trace element concentrations were determined by flame atomic absorption spectroscopy (for Mg, Zn, Ca, and Cu) as well as graphite furnace (for Mn). Data were analyzed by independent t test, Pearson’s correlation analysis, regression analysis, and ANOVA. The serum concentration of Mn, Zn, Ca, Cu, and Mg in panic disorder patients were 0.37 ± 0.30, 0.67 ± 0.20, 99.91 ± 15.15, 0.83 ± 0.23, and 21.14 ± 3.72 mg/L, while those were 0.4163 ± 0.2527, 0.86 ± 0.3, 106.6073 ± 18.6531, 0.8514 ± 0.3646, and 21.37 ± 2.03 mg/L in control subjects, respectively. The serum concentration of Zn decreased significantly (p = 0.001) in patient group. But the differences of the concentration of Mn, Ca, Cu, and Mg between patient and control group were not significant (p = 0.522, p = 0.065, p = 0.800, and p = 0.712, respectively). Socio-economic data reveal that most of the patients were very poor and middle aged. Mean BMIs of the control group (23.74 ± 2.71 kg/m2) and the patient group (22.62 ± 3.74 kg/m2) were within the normal range (18.5–25.0 kg/m2). There was no significant relationship between serum zinc level and BMI of patients (r = 0.038; p = 0.809). So the decreased level of serum zinc in panic disorder patients was not because of other reasons, but rather it may provide a prognostic tool for the diagnosis and treatment of this disease.


Panic disorder Trace elements Socio-economic factors 


  1. 1.
    Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54(4):305–309PubMedGoogle Scholar
  2. 2.
    Kaufman J, Charney D (2000) Comorbidity of mood and anxiety disorders. Depress Anxiety 12(1):69–76CrossRefPubMedGoogle Scholar
  3. 3.
    Diagnostic and Statistical Manual of Mental Disorders (2000) 4th edn. Text rev.: DSM-IV-R. American Psychiatric Association, WashingtonGoogle Scholar
  4. 4.
    Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF (1998) Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl 34:24–28PubMedGoogle Scholar
  5. 5.
    Kushner MG, Sher KJ, Beitman BD (1990) The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 147(6):685–695PubMedGoogle Scholar
  6. 6.
    Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493–505CrossRefPubMedGoogle Scholar
  7. 7.
    Taylor (2006) Panic disorder. BMJ 332:951–955CrossRefPubMedGoogle Scholar
  8. 8.
    Mary LH, Judd LL, James B, David B, Bernard B (1993) Panic Disorder Education Program ISBN 93-3508Google Scholar
  9. 9.
    Roy-Byrne PP, Craske MG, Stein MB (2006) Panic disorder 368(9540):1023–1032Google Scholar
  10. 10.
    Moore DP, Jefferson JW (2004) Handbook of Medical Psychiatry 2nd ed. Elsevier Mosby, St. Louis, pp 162–163Google Scholar
  11. 11.
    Sathyanarayana R, Luigi Z, Jagannatha R (2007) Trace metals, neuromelanin and neurodegeneration. An interesting area for research. Indian J Psychiatr 49(3):154–156CrossRefGoogle Scholar
  12. 12.
    Charles B, Clayman (1989) American Medical Association. Am Med Assoc/Encycl Med 396:605–752Google Scholar
  13. 13.
    Muralidhar LH (2004) Serum trace element levels and the complexity of inter element relations in patients with Parkinson’s disease. J Trace Elem Med Biol 18:163–171CrossRefGoogle Scholar
  14. 14.
    Livesay DA (2003) Conservation of electrostatic properties within enzyme families and superfamilies. Biochemistry 42(12):3464–3473CrossRefPubMedGoogle Scholar
  15. 15.
    Wallwork JC (1987) Cu and central nervous system. Program Food Nutr Sci 11:203–247Google Scholar
  16. 16.
    Vallee B, Coleman J, Auld D (1991) Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc Natl Acad Sci U S A 88:999–1003CrossRefPubMedGoogle Scholar
  17. 17.
    Vallee B, Falchuk K (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79–118PubMedGoogle Scholar
  18. 18.
    Blanchard R, Cousins R (1996) Differential display of intestinal mRNAs regulated by dietary zinc. Proc Natl Acad Sci U S A 93:6863–6868CrossRefPubMedGoogle Scholar
  19. 19.
    Chesters J, Petrie L, Travis A (1990) A requirement for Zn2+ for the induction of thymidine kinase but not ornithine decarboxylase in 3T3 cells stimulated from quiescence. Biochem J 272:525–527PubMedGoogle Scholar
  20. 20.
    Xie X, Smart TG (1991) A physiological role for endogenous zinc in rat hippocampal synaptic neurotransmission. Nature 349:521–524CrossRefPubMedGoogle Scholar
  21. 21.
    Smart TG, Constanti A (1990) Differential effect of zinc on the vertebrate GABA receptor complex. Br J Pharmacol 199:643–654Google Scholar
  22. 22.
    Yeh GC, Bonhaus DW, McNamara JO (1990) Evidence that zinc inhibits N methyl-D-aspartate receptor gated ion channel activation by noncompetitive antagonism of glycine binding. Mol Pharmacol 138:14–19Google Scholar
  23. 23.
    Koh JY, Choi DW (1988) Zinc alters excitatory amino acid neurotoxicity on cortical neurons. J Neurosci 8:2164–2171PubMedGoogle Scholar
  24. 24.
    Liccione JJ, Maines MD (1988) Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. ASPET 247(1):156–161Google Scholar
  25. 25.
    Pfeiffer CC, LaMola S (1983) Zinc and manganese in the schizophrenias. J Orthomol Psychiatry 12(3):28–48Google Scholar
  26. 26.
    Cox IM, Campbell MJ, Dowson D (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337:757–760CrossRefPubMedGoogle Scholar
  27. 27.
    Lidow MS (2003) Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Rev 43(3):285CrossRefGoogle Scholar
  28. 28.
    Seelig SM (1994) Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications. J Am Coll Nutr 13(5):429–446PubMedGoogle Scholar
  29. 29.
    Czupryn M, Falchuk KH, Stankiewicz A, Vallee BL (1993) A Euglena gracilis zinc endonuclease. Biochemistry 32(5):1204–1211CrossRefPubMedGoogle Scholar
  30. 30.
    Karim P, Hossain I, Sadat AFMN, Nahar Z, Hossain K, Hasnat A (2006) Serum level of cadmium, calcium, lead and iron in schizophrenic patients. Dhaka Univ J Pharm Sci 5(1–2):9–13Google Scholar
  31. 31.
    Baker A, Sadat AFMN, Rahman L, Qusar S, Huq I, Hossain I, Hasnat A (2005) Serum trace elements in manic patients. Dhaka Univ J Pharm Sci 4(2):99–102Google Scholar
  32. 32.
    Bergquist J, Bergquist S, Axelsson R, Ekman R (1993) Demonstration of immunoglobulin G with affinity for dopamine in cerebrospinal fluid from psychotic patients. Clin Chim Acta 217(2):129–142CrossRefPubMedGoogle Scholar
  33. 33.
    Wacker WE, Parisi AF (1968) Magnesium metabolism. NEJM 278(14):772–776PubMedGoogle Scholar
  34. 34.
    Hossain I, Islam SN, Khan MNI, Islam S, Hasnat A (2007) Serum level of copper, zinc and manganese in somatization disorder patients. Ger J Psychiatr ISSN 1433–1055Google Scholar
  35. 35.
    Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98(2):109–117CrossRefPubMedGoogle Scholar
  36. 36.
    Maes M, Haese PC, Scharpe S, Hondt P, Cosyns P, Broe ME (1994) Hypozincemia in depression. J Affect Disord 31(2):135–140CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  • Zabun Nahar
    • 1
  • Mohammad Abul Kalam Azad
    • 2
  • Md Ashrafur Rahman
    • 1
  • Mohammad Arifur Rahman
    • 3
  • Wasimul Bari
    • 4
  • Sheikh Nazrul Islam
    • 5
  • Md Saiful Islam
    • 1
  • Abul Hasnat
    • 1
    Email author
  1. 1.Department of Clinical Pharmacy and PharmacologyUniversity of DhakaDhakaBangladesh
  2. 2.Department of Pharmaceutical TechnologyUniversity of DhakaDhakaBangladesh
  3. 3.Department of ChemistryUniversity of DhakaDhakaBangladesh
  4. 4.Department of StatisticsUniversity of DhakaDhakaBangladesh
  5. 5.Institute of Nutrition and Food SciencesUniversity of DhakaDhakaBangladesh

Personalised recommendations